State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
Debora Basile,1 Francesca Simionato,1 Alessandro Cappetta,1 Silvio Ken Garattini,2 Giandomenico Roviello,3 Giuseppe Aprile1 1Department of Oncology, San Bortolo General Hospital, AULSS8 Berica, Vicenza, Italy; 2Department of Oncology, University Hospital, Udine, Italy; 3Department of Health Sciences...
Guardado en:
Autores principales: | Basile D, Simionato F, Cappetta A, Garattini SK, Roviello G, Aprile G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f80be8f1068040e88043836502cb1a78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
por: Antonio Pellino, et al.
Publicado: (2021) -
Biological Significance and Targeting of the FGFR Axis in Cancer
por: Athina-Myrto Chioni, et al.
Publicado: (2021) -
The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research
por: Zhu LL, et al.
Publicado: (2016) -
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
por: Yunju Nam, et al.
Publicado: (2022) -
Diffuse scaly erythematous plaques in patient taking poziotinib
por: Reid Oldenburg, MD, PhD, et al.
Publicado: (2022)